ARGININE-VASOPRESSIN FRAGMENT 4-9 STIMULATES THE ACETYLCHOLINE-RELEASE IN HIPPOCAMPUS OF FREELY-MOVING RATS

被引:27
作者
MAEGAWA, H
KATSUBE, N
OKEGAWA, T
AISHITA, H
KAWASAKI, A
机构
[1] CNS Division, Preclinical Research Department, Minase Research Institute, Mishima, Osaka, 618, 3-1-1 Sakurai, Shimamoto
关键词
D O I
10.1016/0024-3205(92)90087-6
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
We examined the effects of arginine-vasopressin (AVP) C-terminal fragment 4-9, which facilitates learning and memory, on the extracellular acetylcholine (ACh) release in hippocampus of freely-moving rats using the microdialysis technique. Following administration of AVP4-9, p-Glu-Asn-Cys[Cys]-Pro-Arg-Gly-NH2, through the dialysis probe into the hippocampus, ACh levels in dialysates from the hippocampus increased markedly in dose and time dependent manner at 2-2.5 and 2.5-3 Ahr. AVP1-9, the parent peptide, has a similar enhancing effect on ACH release as AVP4-9. Stimulated ACh release by AVP4-9 was significantly inhibited by V1-selective receptor antagonist ([1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid), 2-(O-methyl)-tyrosine]AVP), but not by V2-selective antagonist ([1-(beta-mercapto-beta,beta-cyclopentamethylenepropionic acid), 2-D-Ile, 4-Ile]AVP). From these observations, it is demonstrated that AVP4-9 stimulates the ACh release in rat hippocampus via mediating V1-like vasopressin receptors.
引用
收藏
页码:285 / 293
页数:9
相关论文
共 36 条
[11]   DIFFERENTIAL-EFFECTS OF 4-AMINOPYRIDINE AND 2,4-DIAMINOPYRIDINE ON THE INVIVO RELEASE OF ACETYLCHOLINE AND DOPAMINE IN FREELY MOVING RATS MEASURED BY INTRASTRIATAL DIALYSIS [J].
DAMSMA, G ;
BIESSELS, PTM ;
WESTERINK, BHC ;
DEVRIES, JB ;
HORN, AS .
EUROPEAN JOURNAL OF PHARMACOLOGY, 1988, 145 (01) :15-20
[12]   A SIMPLE, SENSITIVE, AND ECONOMIC ASSAY FOR CHOLINE AND ACETYLCHOLINE USING HPLC, AND ENZYME REACTOR, AND AN ELECTROCHEMICAL DETECTOR [J].
DAMSMA, G ;
WESTERINK, BHC ;
HORN, AS .
JOURNAL OF NEUROCHEMISTRY, 1985, 45 (05) :1649-1652
[13]   CENTRAL TARGET FOR THE BEHAVIORAL-EFFECTS OF VASOPRESSIN NEUROPEPTIDES [J].
DEWIED, D ;
GAFFORI, O ;
VANREE, JM ;
DEJONG, W .
NATURE, 1984, 308 (5956) :276-278
[14]   MECAMYLAMINE PREVENTS THE ENHANCEMENT OF RETENTION INDUCED BY LYSINE VASOPRESSIN IN MICE [J].
FAIMAN, CP ;
DEERAUSQUIN, GA ;
BARATTI, CM .
BEHAVIORAL AND NEURAL BIOLOGY, 1987, 48 (03) :434-439
[15]   ARGININE VASOPRESSIN INDUCES THE EXPRESSION OF C-FOS IN THE MOUSE SEPTUM AND HIPPOCAMPUS [J].
GIRI, PR ;
DAVE, JR ;
TABAKOFF, B ;
HOFFMAN, PL .
MOLECULAR BRAIN RESEARCH, 1990, 7 (02) :131-137
[16]  
GREIDANUS TBV, 1983, PHARMACOL THERAPEUT, V20, P437
[17]  
KENDRICK KM, 1989, METHOD ENZYMOL, V168, P182
[18]   MICRO-INJECTION OF ARGININE8-VASOPRESSIN ANTISERUM INTO THE DORSAL HIPPOCAMPUS ATTENUATES PASSIVE-AVOIDANCE BEHAVIOR IN RATS [J].
KOVACS, GL ;
BUIJS, RM ;
BOHUS, B ;
GREIDANUS, TBV .
PHYSIOLOGY & BEHAVIOR, 1982, 28 (01) :45-48
[19]   FACILITATION OF AVOIDANCE-BEHAVIOR BY VASOPRESSIN FRAGMENTS MICROINJECTED INTO LIMBIC-MIDBRAIN STRUCTURES [J].
KOVACS, GL ;
VELDHUIS, HD ;
VERSTEEG, DHG ;
DEWIED, D .
BRAIN RESEARCH, 1986, 371 (01) :17-24
[20]   ARGININE-VASOPRESSIN CONTENT OF HIPPOCAMPUS AND AMYGDALA DURING PASSIVE-AVOIDANCE BEHAVIOR IN RATS [J].
LACZI, F ;
GAFFORI, O ;
DEKLOET, ER ;
DEWIED, D .
BRAIN RESEARCH, 1983, 280 (02) :309-315